Why the study?
To examine whether septal myectomy can alter arrhythmogenic risk trajectory in obstructive HCM and how treatment outcomes compare with the HCM Risk-SCD calculator.
Does septal myectomy reduce the risk of sudden cardiac death and malignant arrhythmias in patients with obstructive hypertrophic cardiomyopathy?
Design
Review article
Key result
Septal myectomy is examined for its potential to alter the trajectory of arrhythmogenic risk and sudden cardiac death in hypertrophic cardiomyopathy compared to the HCM Risk-SCD calculator.
Authors
Loading...
Septal myectomy may reduce arrhythmia risk in obstructive HCM but does not replace ICDs; leaves open its impact on SCD stratification versus the HCM Risk-SCD calculator.
Does septal myectomy reduce the risk of sudden cardiac death and malignant arrhythmias in patients with obstructive hypertrophic cardiomyopathy?
This review explores the potential of septal myectomy to provide an additional protective effect against malignant arrhythmias and sudden cardiac death in patients with obstructive hypertrophic cardiomyopathy.
Salagaev et al. (2026) conducted a review in Hypertrophic cardiomyopathy. Septal myectomy was evaluated on Sudden cardiac death and malignant arrhythmias. Septal myectomy is examined for its potential to alter the trajectory of arrhythmogenic risk and sudden cardiac death in hypertrophic cardiomyopathy compared to the HCM Risk-SCD calculator.